Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-14 09:24 am Purchase | 2025-10-06 | 13G | Travere Therapeutics, Inc. TVTX | Perceptive Advisors LLC | 4,895,615 5.500% | 3,050,060 (+165.27%) | Filing History |
| 2025-08-15 12:30 pm Purchase | 2025-06-30 | 13G | Rockwell Medical, Inc. RMTI | Armistice Capital, LLC | 8,876,000 9.960% | 8,876,000 (New Position) | Filing History |
| 2025-08-07 10:34 am Purchase | 2025-07-31 | 13G | Travere Therapeutics, Inc. TVTX | JANUS HENDERSON GROUP PLC JHG | 11,339,864 12.800% | 3,772,901 (+49.86%) | Filing History |
| 2025-07-29 2:41 pm Purchase | 2025-06-30 | 13G | Travere Therapeutics, Inc. TVTX | The Vanguard Group | 5,994,283 6.740% | 980,263 (+19.55%) | Filing History |
| 2025-05-15 3:13 pm Purchase | 2025-03-31 | 13G | Travere Therapeutics, Inc. TVTX | Armistice Capital, LLC | 8,872,000 9.990% | 1,514,000 (+20.58%) | Filing History |
| 2025-05-15 10:47 am Sale | 2025-03-31 | 13G | Travere Therapeutics, Inc. TVTX | Rock Springs Capital Management LP | 2,921,196 3.300% | -2,052,453 (-41.27%) | Filing History |
| 2025-05-15 06:18 am Purchase | 2025-03-31 | 13G | Travere Therapeutics, Inc. TVTX | MACQUARIE GROUP LTD | 4,797,314 5.410% | 537,757 (+12.62%) | Filing History |
| 2025-05-14 11:48 am Purchase | 2025-03-31 | 13G | Travere Therapeutics, Inc. TVTX | JANUS HENDERSON GROUP PLC JHG | 7,566,963 8.500% | 7,534,783 (+23414.49%) | Filing History |
| 2025-04-30 11:22 am Sale | 2025-03-31 | 13G | Travere Therapeutics, Inc. TVTX | The Vanguard Group | 5,014,020 5.650% | -1,728,145 (-25.63%) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Travere Therapeutics, Inc. TVTX | BlackRock Inc. BLK | 6,689,435 7.500% | -1,328,857 (-16.57%) | Filing History |
| 2025-02-14 5:22 pm Sale | 2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Armistice Capital, LLC | 7,358,000 9.620% | -290,000 (-3.79%) | Filing History |
| 2025-02-14 4:06 pm Sale | 2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Woodline Partners LP | 2,114,056 2.400% | -2,226,284 (-51.29%) | Filing History |
| 2025-02-14 09:10 am Purchase | 2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Rock Springs Capital Management LP | 4,973,649 5.720% | 561,666 (+12.73%) | Filing History |
| 2025-02-07 07:44 am Sale | 2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX | MACQUARIE GROUP LTD | 4,259,557 4.900% | -486,587 (-10.25%) | Filing History |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX | BlackRock Inc. BLK | 8,018,292 9.400% | 28,272 (+0.35%) | Filing History |
| 2025-01-31 10:09 am Sale | 2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX | The Vanguard Group | 6,742,165 7.750% | -159,985 (-2.32%) | Filing History |
| 2024-11-14 5:13 pm Purchase | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | Armistice Capital, LLC | 7,648,000 10.000% | 264,000 (+3.58%) | Filing History |
| 2024-11-14 1:01 pm Purchase | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | Woodline Partners LP | 4,340,340 5.700% | 4,340,340 (New Position) | Filing History |
| 2024-11-14 09:46 am Sale | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital, LP | 531,857 0.700% | -6,990,424 (-92.93%) | Filing History |
| 2024-11-12 5:56 pm Unchanged | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | The Vanguard Group | 6,902,150 9.020% | 0 (Unchanged) | Filing History |